BILLEV PHARMA ApS: Financial statements 2020
CVR: 81814813
Source: annual report 2020, Danish Business Authority
01/05/2019 – 30/04/2020
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 21,427,861 and a net result of DKK 3,786,711 compared with DKK 2,493,022 the year before. That is an increase of 22.5% compared with the year before. Equity in the 2020 report amounted to DKK 4,106,711. The solvency ratio was 50.9%. The company had 16 employees in the financial year.
- Gross Profit
- DKK 21,427,861
- Profit/Loss
- DKK 3,786,711
- Equity
- DKK 4,106,711
- Total Assets
- DKK 8,064,645
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 21.4 mio. | 3.8 mio. | 4.1 mio. | 16 |
| 2019 | - | 17.5 mio. | 2.5 mio. | 2.8 mio. | 14 |
| 2018 | - | 17.1 mio. | 3.7 mio. | 4 mio. | 13 |
| 2017 | - | 14.6 mio. | 2.1 mio. | 2.4 mio. | 13 |
| 2016 | - | - | 2 mio. | 2.3 mio. | - |
How creditworthy is BILLEV PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Wencke van Arkens and Ulrikke Lynge Jensen. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.